| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cabozantinib S-malate | FAERS: 2 | US FAERS | |
| 2 | Vardenafil Dihydrochloride | FAERS: 2 | OFFSIDES US FAERS | |
| 3 | Atomoxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 4 | Lidocaine, Prilocaine Drug Combination | FAERS: 1 | US FAERS | |
| 5 | Sorafenib | FAERS: 1 | US FAERS | |
| 6 | empagliflozin | FAERS: 1 | US FAERS | |
| 7 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 8 | Acetylcysteine | OFFSIDES | ||
| 9 | Bisacodyl | OFFSIDES | ||
| 10 | Chlorhexidine | OFFSIDES | ||
| 11 | Cyproterone Acetate | OFFSIDES | ||
| 12 | Dasatinib | Canada Vigilance: 1 | Canada Vigilance | |
| 13 | Ipratropium | OFFSIDES | ||
| 14 | Rivastigmine | OFFSIDES | ||
| 15 | Zoledronic Acid | OFFSIDES | ||
| 16 | periciazine | OFFSIDES | ||
| 17 | tizanidine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.